roen glp-1 Medications for Weight Loss with the Ro Body Program Regeneron & Hansoh's GLP-1 Deal

A previous systematic review of randomized controlled trials concluded that GLP-1 RAs did not significantly increase overall cancer risk but raised questions about specific sites such as the pancreas and thyroid (D'Alessio et al., 2015

Hayes MR, Mietlicki-Baase EG, Kanoski SE, De Jonghe BC (2014)

The reason behind the drugs immense popularity is its effectiveness in managing weight, a phenomenon enthusiastically promoted by social media influencers

Mistake #1: Not Eating Enough Protein The problem: When appetite tanks, protein is often the first thing to go

6 Malhotra A, Grunstein RR, Fietze I, Weaver TE, Redline S, Azarbarzin A, Sands SA, Schwab RJ, Dunn JP, Chakladar S, Bunck MC, Bednarik J

However, semaglutide has a longer track record and more safety data in broader populations